Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Kuvatris Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 0 | 6 | +6 |
| Shares | 0 | 55.3K | +55.3K |
| Value | $0 | $155.0K | +$155.0K |
New holders (6)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 15,000 | $59.0K | 0.00% |
| Jane Street Group, LLC | 18,025 | $43.0K | 0.00% |
| Virtu Financial LLC | 14,108 | $34.0K | 0.00% |
| UBS Group AG | 6,206 | $15.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,868 | $4.00K | 0.00% |
| Royal Bank of Canada | 68 | $0 | 0.00% |
Sold out (0)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.